Press Release: Secures Growth Capital Infusion from Curewell Capital
Summary
Partnership with Curewell Accelerates Growth and Innovation of Best-in-Class Technology for Infusion Providers and Specialty PharmaciesAUSTIN | DALLAS, March 2, 2023 WeInfuse, the premier software and technology platform for infusion therapy and medication delivery in the U.S., announced a significant growth equity investment from Curewell Capital to support the companys continued expansion and strategic initiatives. Prior to founding OrderInsite, a leading provider of cloud-based pharmacy supply chain and investment management software, Lazenby was the CEO of Emdeon (now Change Healthcare), the nations largest health information network. Michael, Ceron, and George bring a wealth of experience in the infusion, pharmacy, and healthcare technology space, said Bryan Johnson, Co-Founder and CEO of WeInfuse. We are thrilled to partner with co-founders Bryan Johnson and Reece Norris, along with the entire WeInfuse team, to further accelerate the development of new and existing initiatives and products.WeInfuse is the premier software and technology provider for infusion therapy and medication delivery in the U.S. Its powerful, intuitive features for infusion workflows and a robust reporting and analytics engine help take the confusion out of infusion.Curewell Capital is a growth-oriented investment firm focused on building industry-leading healthcare companies.